A total of 10,402 pregnant women registered for antenatal care in the 13 MMS-assigned clinics, of whom 648 (6.2%) had an initial Hb<10 g/dL, were started on an anemia treatment protocol, and excluded from this analysis (data not shown). The gene discussed is GSTM1; the disease is anemia.